While the risk of SARS-CoV-2 infection and/or COVID-19 disease progression in the general population has been largely assessed, its impact on HIV-positive individuals remains unclear. We present clinical and immunological data collected in a cohort of HIV-infected young individuals during the first wave of COVID-19 pandemic. SARS-CoV-2 RNA, virus-specific antibodies, as well as the expression of factors involved in the anti-viral immune response were analyzed. Moreover, we set up an in vitro coinfection assay to study the mechanisms correlated to the coinfection process. Our results did not show any increased risk of severe COVID-19 in HIV-positive young individuals. In those subjects who contracted SARS-CoV-2 infection, an increase in IL-10 expression and production was observed. Furthermore, in the in vitro coinfection assay, we revealed a reduction in SARS-CoV-2 replication associated to an upregulation of IL-10. We speculate that IL-10 could play a crucial role in the course of SARS-CoV-2 infection in HIV-positive individuals. These results might help defining clinical management of HIV/SARS-CoV-2 co-infected young individuals, or putative indications for vaccination schedules in this population.

Immunological characterization of hiv and sars-cov-2 coinfected young individuals / C. Vanetti, D. Trabattoni, M. Stracuzzi, A. Amendola, C. Fappani, V. Rubinacci, C. Fenizia, L. Gianolio, M. Biasin, A. Dighera, I. Saulle, E. Tanzi, G. Zuccotti, M. Clerici, V. Giacomet. - In: CELLS. - ISSN 2073-4409. - 10:11(2021), pp. 3187.1-3187.13. [10.3390/cells10113187]

Immunological characterization of hiv and sars-cov-2 coinfected young individuals

C. Vanetti
Primo
;
D. Trabattoni
Secondo
;
M. Stracuzzi;A. Amendola;C. Fappani;V. Rubinacci;C. Fenizia;L. Gianolio;M. Biasin;A. Dighera;I. Saulle;E. Tanzi;G. Zuccotti;M. Clerici
Penultimo
;
V. Giacomet
Ultimo
2021

Abstract

While the risk of SARS-CoV-2 infection and/or COVID-19 disease progression in the general population has been largely assessed, its impact on HIV-positive individuals remains unclear. We present clinical and immunological data collected in a cohort of HIV-infected young individuals during the first wave of COVID-19 pandemic. SARS-CoV-2 RNA, virus-specific antibodies, as well as the expression of factors involved in the anti-viral immune response were analyzed. Moreover, we set up an in vitro coinfection assay to study the mechanisms correlated to the coinfection process. Our results did not show any increased risk of severe COVID-19 in HIV-positive young individuals. In those subjects who contracted SARS-CoV-2 infection, an increase in IL-10 expression and production was observed. Furthermore, in the in vitro coinfection assay, we revealed a reduction in SARS-CoV-2 replication associated to an upregulation of IL-10. We speculate that IL-10 could play a crucial role in the course of SARS-CoV-2 infection in HIV-positive individuals. These results might help defining clinical management of HIV/SARS-CoV-2 co-infected young individuals, or putative indications for vaccination schedules in this population.
HIV; COVID-19; SARS-CoV-2; IL-10; immune response; children; young adult; Calu-3
Settore MED/04 - Patologia Generale
Settore BIO/13 - Biologia Applicata
Article (author)
File in questo prodotto:
File Dimensione Formato  
cells-10-03187-v2.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 1.94 MB
Formato Adobe PDF
1.94 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Caricamento pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/884776
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
social impact